VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 1 filers reported holding VERVE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,911,908 | -6.5% | 521,260 | +32.2% | 0.08% | -8.0% |
| Q2 2023 | $7,395,394 | +32.7% | 394,421 | +2.1% | 0.09% | +15.8% |
| Q1 2023 | $5,572,840 | -23.5% | 386,466 | +2.7% | 0.08% | -21.6% |
| Q4 2022 | $7,280,960 | -43.5% | 376,277 | +0.3% | 0.10% | -46.1% |
| Q3 2022 | $12,881,000 | +462.0% | 374,995 | +150.0% | 0.18% | +414.3% |
| Q2 2022 | $2,292,000 | -33.0% | 150,000 | 0.0% | 0.04% | -37.5% |
| Q1 2022 | $3,423,000 | -47.3% | 150,000 | -14.8% | 0.06% | -39.8% |
| Q4 2021 | $6,490,000 | -31.8% | 176,027 | -13.1% | 0.09% | -40.0% |
| Q3 2021 | $9,518,000 | -23.7% | 202,500 | -2.1% | 0.16% | -33.2% |
| Q2 2021 | $12,467,000 | – | 206,921 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,508,809 | $57,251,000 | 8.18% |
| Alphabet Inc. | 10,974,011 | $250,427,000 | 8.12% |
| M28 Capital Management LP | 178,500 | $4,073,000 | 3.74% |
| Casdin Capital, LLC | 3,138,167 | $71,613,000 | 3.21% |
| Ally Bridge Group (NY) LLC | 105,360 | $2,404,000 | 1.78% |
| Redmile Group, LLC | 1,835,328 | $41,882,000 | 1.31% |
| Cormorant Asset Management, LP | 700,710 | $15,990,000 | 1.23% |
| Novo Holdings A/S | 750,000 | $17,115,000 | 0.90% |
| Artal Group S.A. | 400,000 | $9,128,000 | 0.38% |
| PFM Health Sciences, LP | 369,765 | $8,438,000 | 0.32% |